Tag: growing-number
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan to pay $465 mn over EpiPen overcharges to Medicaid
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday. The settlement with the Department of Justice and some other regulators resolves questions about Mylan's classification of EpiPen as a generic drug, the drugmaker said. Mylan said it…
-
Mylan pays $465 million to settle EpiPen Medicaid rebate dispute
(Reuters) – Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. The company has come under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade,…
-
Mylan pays $465 million to settle EpiPen Medicaid rebate dispute
(Reuters) – Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. The company has come under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade,…
-
Some ex-NFL players seek to re-work $1 billion concussion settlement
By Natalie Pompilio PHILADELPHIA (Reuters) – Lawyers representing some former NFL players urged a federal appeals court on Thursday to scrap the league’s $1 billion concussion settlement because it does not cover potential victims of a degenerative brain disease linked to repeated blows to the head. The deal should include future payments for chronic traumatic…
-
Some ex-NFL players seek to re-work $1 bln concussion settlement
By Natalie Pompilio PHILADELPHIA, Nov 19 (Reuters) – Lawyers representing some former NFL players urged a federal appeals court on Thursday to scrap the league’s $1 billion concussion settlement because it does not cover potential victims of a degenerative brain disease linked to repeated blows to the head. The deal should include future payments for…
-
U.S. clears genetically modified salmon for human consumption
By Julie Steenhuysen and Tom Polansek CHICAGO (Reuters) – U.S. health regulators on Thursday cleared the way for a type of genetically engineered Atlantic salmon to be farmed for human consumption – the first such approval for an animal whose DNA has been scientifically modified. Five years ago, the U.S. Food and Drug Administration first…